Latest News

A team of researchers from Yale Department of Cellular & Molecular Physiology led by Elena Gracheva and Slav Bagriantsev explore a physiological mechanism that enables hibernating mammals to survive for many months without water.

Yale researchers representing a range of disciplines have been awarded grants through the National Institutes of Health (NIH) Helping to End Addiction Long-term Initiative (HEAL). This national effort provides $945 million in total funding to support a variety of research projects that tackle the opioid addiction and overdose crisis.

A 2018 study by Marc Potenza, MD, PhD, Professor of Psychiatry, in the Child Study Center and of Neuroscience, is cited in a Wall Street Journal Report that investigates brain differences that cause boys to be more interested in video games and girls to spend more time on social media.

All vertebrates possess a primitive network in which the retina sends signals directly to the superior colliculus, an area of the brain that processes visual stimuli. In a more recently evolved pathway, signals from the retina are received in the thalamus and are relayed to the cortex, the brain’s seat of higher-order thinking.

Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, was a guest on the Australian television news program Planet America. She discussed the science around the recent outbreak of vaping-related illnesses on an episode titled, "What's Killing America's Vapers?"

For 20 years, WHRY has been building a lasting, expanding legacy to make science better so people can live better lives.

Arthur L. Horwich, MD, Sterling Professor of Genetics and professor of pediatrics, and his colleague F. Ulrich Hartl, from the Max Planck Institute, will share a 2020 Breakthrough Prize. This prize was developed by Sergey Brin, Mark Zuckerberg, Jack Ma, and Yuri Milner, together with their families, to honor the most accomplished life scientists.

The researchers reaffirmed that inflammation occurs in the hypothalamus as early as three days after consumption of a high-fat diet, even before the body begins to display signs of obesity.

John H. Krystal, MD, Chair of the Yale Department of Psychiatry, spoke to the Connecticut Health I-Team for a story about the new nasal spray Spravato, which after receiving Food and Drug Administration approval in March is being prescribed for treatment-resistant depression. Krystal is best known for leading the discovery of the rapid antidepressant effects of ketamine in depressed patients. Spravato's chemical name is esketamine, a derivative of ketamine.